Literature DB >> 571271

CNS changes in hyperbilirubinemia. Functional implications.

J Y Jew, D Sandquist.   

Abstract

Hyperbilirubinemia is a recognized etiologic factor in motor and hearing disorders associated with cerebral palsy. Its role in more subtle forms of neurological impairment is more controversial. Using a mutant animal model, which develops symptoms and signs closely resembling the human kernicterus syndrome, neurons of hippocampus, cerebral cortex, cochlear nuclei, losuc ceruleus, and olfactory bulb were examined by electron microscopy. Pathological changes, observed in all areas studied, consisted of mitochondrial and endoplasmic enlargement and vacuolation, with glycogen deposition; increased extracellular space; myelin figures; and degenerating changes in nerve terminals. If we make the assumption that pathologic changes in the human infant with neonatal jaundice are similar to changes in the animal model, then the widespread involvement of CNS neurons in all cortical areas examined may well help to explain the syndromes of minimal cerebral dysfunction reported in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571271     DOI: 10.1001/archneur.1979.00500390067007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

1.  MGE-Like Neural Progenitor Cell Survival and Expression of Parvalbumin and Proenkephalin in a Jaundiced Rat Model of Kernicterus.

Authors:  Fu-Chen Yang; Jay L Vivian; Catherine Traxler; Steven M Shapiro; John A Stanford
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

2.  Auditory nerve and brain stem responses in homozygous jaundiced Gunn rats.

Authors:  G Levi; H Sohmer; J Kapitulnik
Journal:  Arch Otorhinolaryngol       Date:  1981

3.  Two proteins associated with cerebellar hypoplasia in jaundiced Gunn rats.

Authors:  S Aono; H Sato; R Semba; S Kashiwamata
Journal:  Neurochem Res       Date:  1983-06       Impact factor: 3.996

4.  Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1).

Authors:  Florinda Gennuso; Cristina Fernetti; Cataldo Tirolo; Nuccio Testa; Francesca L'Episcopo; Salvo Caniglia; Maria Concetta Morale; J Donald Ostrow; Lorella Pascolo; Claudio Tiribelli; Bianca Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

5.  Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse.

Authors:  Martin D Haustein; David J Read; Joern R Steinert; Nadia Pilati; David Dinsdale; Ian D Forsythe
Journal:  J Physiol       Date:  2010-10-11       Impact factor: 5.182

Review 6.  Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.

Authors:  Sanjiv B Amin; Tristram Smith; Geralyn Timler
Journal:  Pediatr Res       Date:  2018-10-23       Impact factor: 3.756

7.  Multi-neuronal recordings in the Basal Ganglia in normal and dystonic rats.

Authors:  Mark S Baron; Kunal D Chaniary; Ann C Rice; Steven M Shapiro
Journal:  Front Syst Neurosci       Date:  2011-08-31

8.  Hyperactivity in the Gunn rat model of neonatal jaundice: age-related attenuation and emergence of gait deficits.

Authors:  John A Stanford; Jeffrey M Shuler; Stephen C Fowler; Kimberly G Stanford; Delin Ma; Douglas C Bittel; Jean-Baptiste Le Pichon; Steven M Shapiro
Journal:  Pediatr Res       Date:  2014-12-17       Impact factor: 3.756

9.  Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.

Authors:  Shoko Miura; Keiko Tsuchie; Michiyo Fukushima; Ryosuke Arauchi; Toshiko Tsumori; Koji Otsuki; Maiko Hayashida; Sadayuki Hashioka; Rei Wake; Tsuyoshi Miyaoka; Masatoshi Inagaki; Arata Oh-Nishi
Journal:  Pediatr Res       Date:  2021-03-31       Impact factor: 3.756

10.  The effect of bilirubin on the excitability of mitral cells in the olfactory bulb of the rat.

Authors:  Xiao-Juan Chen; Hui-Qun Zhou; Hai-Bo Ye; Chun-Yan Li; Wei-Tian Zhang
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.